#biopharmaceutical consulting | Explore Tumblr Posts and Blogs

sudheervanguri · 5 days

Text

opportunity to work remotely as a Senior Regulatory Affairs Associate at Parexel. Learn about the qualifications, responsibilities, and locations available in India, including Remote, Hyderabad, and Mumbai. About Parexel: Parexel is a renowned consulting firm specializing in helping biopharmaceutical and medical device companies navigate regulatory challenges. Join a dynamic team focused on innovation and collaboration, with opportunities for continuous learning and career growth. Role Overview: Senior Regulatory Affairs Associate Qualifications: Around 4-8 years of relevant experience in drug product life cycle management Good understanding of global regulatory frameworks, including EU/US procedures Experience in handling CMC-related queries and submissions Working knowledge of Regulatory Information Management Systems like Veeva Vault Strong communication and mentoring skills Ability to work independently and collaborate effectively with cross-functional teams Responsibilities: Around 4-8 years of relevant experience in handling of pre and post approval life cycle management of drug products (small molecules as well as biologics) in various markets. Good understanding of regulatory framework, including regional trends, for various types of applications and procedures Contribute to preparation (including authoring where relevant) and delivery of simple, and with experience, increasingly more complex regulatory maintenance submissions from either a global and/or regional perspective. Working knowledge of EU/US regulatory procedures including post approval requirements. Knowledge of ROW markets regulatory legislations would be an added advantage Experience in handling CMC related health authority queries Good understanding of regulatory framework, including regional trends, for various types of applications and procedures for small and large molecules across all regions as well as knowledge of global pharmaceutical legislation and guidance specifically linked to regulatory CMC aspects in the ICH countries. Preparation and review of Marketing Authorization Applications & Variations for various types of medicinal products (Orals & Parenterals) for filing in EU through different types of procedures (DCP/MRP/National Procedures). Preparation of documentation for different types of Variation procedures like Super grouping, Grouping and Work-sharing to the Marketing Authorizations. Regulatory review of DMFs, batch records, specifications, and stability data to ensure their compliance with the regulatory requirements. Providing regulatory impact assessment for change proposals and identification of required documentation for EU submissions Liaise closely with cross-functional members with aligned product responsibilities. Execute and maintain submission delivery plans, submission content plans, and proactively provide status updates to designated stakeholders. To prepare, review and submit safety variations to Health Authorities and perform post Approval CMC related updates. Working experience in Regulatory Information Management Systems like Veeva Vault. Strong communications skills and ability to guide and mentor team members [caption id="attachment_52372" align="aligncenter" width="930"] Parexel Regulatory Affairs Job Vacancies - Senior Regulatory Affairs Associate[/caption] Success Profile: Are you a communicator, detail-oriented problem solver with a strategic mindset? Parexel values individuals who can build relationships, drive results, and contribute to strategic regulatory initiatives. How to Apply: Interested candidates can apply for the Remote Senior Regulatory Affairs Associate position at Parexel through the official job listing here.

0 notes

spookysaladchaos · 7 days

Text

Global Top 5 Companies Accounted for 73% of total SUS (Single Use System) for Biopharma Process market (QYResearch, 2022)

Single-use systems (SUS) refers to biopharmaceutical manufacturing (bioprocessing) equipment designed to be used once (or for a single manufacturing campaign) and then discarded.

This report focuses on devices and consumables, mainly including single-use bioreactors, disposable sterile bags, and disposable filtration systems.

According to the new market research report “Global SUS (Single Use System) for Biopharma Process Market Report 2023-2029”, published by QYResearch, the global SUS (Single Use System) for Biopharma Process market size is projected to reach USD 15.47 billion by 2029, at a CAGR of 19.0% during the forecast period.

Figure. Global SUS (Single Use System) for Biopharma Process Market Size (US$ Million), 2018-2029

Figure. Global SUS (Single Use System) for Biopharma Process Top 11 Players Ranking and Market Share (Ranking is based on the revenue of 2022, continually updated)

The global key manufacturers of SUS (Single Use System) for Biopharma Process include Danaher, Thermo Fisher, Sartorius, Merck, Lepure China, ABEC, JYSS Bio-Engineering, Duoning Biotechnology, Tofflon, AUSTAR, etc. In 2022, the global top five players had a share approximately 73.0% in terms of revenue.

About QYResearch

QYResearch founded in California, USA in 2007.It is a leading global market research and consulting company. With over 16 years’ experience and professional research team in various cities over the world QY Research focuses on management consulting, database and seminar services, IPO consulting, industry chain research and customized research to help our clients in providing non-linear revenue model and make them successful. We are globally recognized for our expansive portfolio of services, good corporate citizenship, and our strong commitment to sustainability. Up to now, we have cooperated with more than 60,000 clients across five continents. Let’s work closely with you and build a bold and better future.

QYResearch is a world-renowned large-scale consulting company. The industry covers various high-tech industry chain market segments, spanning the semiconductor industry chain (semiconductor equipment and parts, semiconductor materials, ICs, Foundry, packaging and testing, discrete devices, sensors, optoelectronic devices), photovoltaic industry chain (equipment, cells, modules, auxiliary material brackets, inverters, power station terminals), new energy automobile industry chain (batteries and materials, auto parts, batteries, motors, electronic control, automotive semiconductors, etc.), communication industry chain (communication system equipment, terminal equipment, electronic components, RF front-end, optical modules, 4G/5G/6G, broadband, IoT, digital economy, AI), advanced materials industry Chain (metal materials, polymer materials, ceramic materials, nano materials, etc.), machinery manufacturing industry chain (CNC machine tools, construction machinery, electrical machinery, 3C automation, industrial robots, lasers, industrial control, drones), food, beverages and pharmaceuticals, medical equipment, agriculture, etc.

For more information, please contact the following e-mail address:

Email: [email protected]

Website: https://www.qyresearch.com

#SUS (Single Use System) for Biopharma Process

0 notes

fmarkets · 9 days

Text

AVXL's Lackluster Financial Performance Raises Concerns for Investors $AVXL #Nasdaq

Anavex Life Sciences Corp's Financial Results: Assessing the Potential Impact Anavex Life Sciences Corp, a biopharmaceutical company, recently reported its financial results for the period ending March 31, 2024. The company experienced a narrowed net loss per share compared to the previous year, while the revenue remained unchanged. In addition, various law firms have initiated legal consultations and filed class-action lawsuits against Anavex. This article aims to analyze the significance of these financial results and explore the potential implications

0 notes

lanettcdmo · 12 days

Text

Dynamic Landscape of Pharmaceuticals: Key Trends and the Role of Contract Manufacturing

Introduction: In the dynamic realm of pharmaceuticals, staying abreast of key trends is essential for industry players seeking to innovate and adapt. From precision medicine to digital health, the landscape is constantly evolving, presenting both challenges and opportunities. In this blog post, we’ll explore the pivotal role of contract manufacturing and regulatory support amidst these trends, shedding light on their significance in driving progress and ensuring compliance in the pharmaceutical industry.

Precision Medicine and Contract Manufacturing:

Precision medicine, with its focus on personalized therapies, presents unique manufacturing challenges due to the need for small batch sizes and customized formulations. Contract manufacturing organizations (CMOs) are playing a vital role in this space by offering flexible manufacturing solutions tailored to the specific needs of precision medicine products.

CMOs specializing in advanced manufacturing technologies, such as continuous manufacturing and 3D printing, are enabling pharmaceutical companies to accelerate the development and production of personalized therapies, enhancing efficiency and scalability.

Digital Health and Regulatory Support:

The integration of digital health solutions into pharmaceutical products necessitates robust regulatory support to ensure compliance with evolving standards and guidelines. Regulatory consulting firms provide invaluable expertise in navigating the complex regulatory landscape, helping companies secure approvals for digital therapeutics, mobile health apps, and virtual clinical trials.

Regulatory support extends beyond product approvals to encompass post-market surveillance, pharmacovigilance, and compliance with data privacy regulations. By partnering with regulatory experts, pharmaceutical companies can mitigate risks, expedite market entry, and maintain compliance throughout the product lifecycle.

Biopharmaceuticals and Contract Manufacturing:

The growing demand for biopharmaceuticals, driven by their potential to address unmet medical needs, is driving expansion in the contract manufacturing market. CMOs with expertise in bioprocessing and cell culture technologies are in high demand, offering end-to-end manufacturing services for biologics, biosimilars, and cell and gene therapies.

Strategic partnerships between pharmaceutical companies and CMOs enable access to specialized capabilities and capacity, allowing for faster development and commercialization of biopharmaceutical products while mitigating capital investment risks.

Sustainability and Regulatory Compliance:

Sustainability considerations are increasingly influencing regulatory requirements in the pharmaceutical industry, with agencies emphasizing environmental stewardship and responsible manufacturing practices. Regulatory support firms assist companies in navigating sustainability regulations, ensuring compliance with environmental, health, and safety standards.

From green chemistry principles to waste reduction strategies, pharmaceutical companies are embracing sustainable manufacturing practices with the guidance of regulatory experts, aligning with global sustainability goals and enhancing their corporate social responsibility initiatives.

Conclusion:

As the pharmaceutical industry continues to evolve, the roles of contract manufacturing and regulatory support are becoming increasingly indispensable. From facilitating the production of precision medicines to navigating complex regulatory frameworks, these partners enable pharmaceutical companies to innovate responsibly and bring life-saving therapies to market efficiently. By leveraging the expertise of contract manufacturers and regulatory consultants, pharmaceutical companies can navigate the ever-changing landscape with confidence, driving progress and ensuring compliance in an era of unprecedented transformation.

#health #manufacturing #equipment

0 notes

marketinsight1234 · 22 days

Text

Cold Chain Packaging Market: Global Industry Analysis and Forecast 2023 – 2030

The Global Market for Cold Chain Packaging Estimated at USD 27130 Million In the Year 2022, Is Projected To Reach A Revised Size Of USD 115100 Million By 2030, Growing At A CAGR Of 19.90% Over The Forecast Period 2022-2030.

The Cold Chain Packaging Market is a critical segment within the broader packaging industry, primarily focused on preserving and maintaining the integrity of temperature-sensitive products during transportation and storage. This market plays a pivotal role in supporting industries such as pharmaceuticals, food and beverages, and healthcare, where the maintenance of specific temperature conditions is essential for product efficacy and safety. With the increasing globalization of supply chains and the growing demand for perishable goods, the cold chain packaging market has witnessed significant growth in recent years.

Get Full PDF Sample Copy of Report: (Including Full TOC, List of Tables & Figures, Chart) @

https://introspectivemarketresearch.com/request/16601

Leading players involved in the Cold Chain Packaging Market include:

Cold Chain Technologies (U.S.), Peli BioThermal (U.S.), Orora Group (Australia), Sonoco ThermoSafe (U.S.), CREOPACK (Canada), Sofrigam (France), Intelsius (U.K.), Nordic Cold Chain Solutions (U.S.), Tempack (Spain), Cryopak (U.S.), Softbox Systems (U.K.), Sealed Air Corporation (U.S.) And Other Major Players

Market Driver:

One of the key drivers propelling the Cold Chain Packaging Market is the surge in demand for biopharmaceuticals and specialty drugs. As pharmaceutical companies continue to develop advanced and temperature-sensitive medications, the need for reliable and efficient cold chain packaging solutions becomes paramount. These intricate drugs often require strict temperature control to ensure their effectiveness and safety, creating a demand for innovative packaging solutions equipped with temperature-monitoring technologies. The increasing prevalence of chronic diseases and the expansion of the pharmaceutical sector further accentuate the importance of a robust cold chain packaging infrastructure.

Market Opportunity:

An emerging opportunity in the Cold Chain Packaging Market lies in the integration of sustainable and eco-friendly packaging materials and practices. As environmental concerns gain prominence across industries, there is a growing demand for packaging solutions that minimize carbon footprint and reduce waste. Manufacturers in the cold chain packaging sector have the chance to capitalize on this trend by developing and promoting packaging solutions that are not only effective in temperature control but also environmentally friendly. Innovations in recyclable materials and energy-efficient packaging technologies represent a significant market opportunity, aligning with the broader global shift towards sustainable practices.

The latest research on the Cold Chain Packaging market provides a comprehensive overview of the market for the years 2023 to 2030. It gives a comprehensive picture of the global Cold Chain Packaging industry, considering all significant industry trends, market dynamics, competitive landscape, and market analysis tools such as Porter's five forces analysis, Industry Value chain analysis, and PESTEL analysis of the Cold Chain Packaging market. Moreover, the report includes significant chapters such as Patent Analysis, Regulatory Framework, Technology Roadmap, BCG Matrix, Heat Map Analysis, Price Trend Analysis, and Investment Analysis which help to understand the market direction and movement in the current and upcoming years. The report is designed to help readers find information and make decisions that will help them grow their businesses. The study is written with a specific goal in mind: to give business insights and consultancy to help customers make smart business decisions and achieve long-term success in their particular market areas.

If You Have Any Query Cold Chain Packaging Market Report, Visit:

https://introspectivemarketresearch.com/inquiry/16601

Segmentation of Cold Chain Packaging Market:

By Product Type

EPS Containers

PUR Containers

Pallet Shippers

Vacuum Insulated Panels

Others

By Application

Food

Dairy

Pharmaceutical

Others

Market Segment by Regions: -

North America (US, Canada, Mexico)

Eastern Europe (Bulgaria, The Czech Republic, Hungary, Poland, Romania, Rest of Eastern Europe)

Western Europe (Germany, UK, France, Netherlands, Italy, Russia, Spain, Rest of Western Europe)

Asia Pacific (China, India, Japan, South Korea, Malaysia, Thailand, Vietnam, The Philippines, Australia, New Zealand, Rest of APAC)

Middle East & Africa (Turkey, Bahrain, Kuwait, Saudi Arabia, Qatar, UAE, Israel, South Africa)

South America (Brazil, Argentina, Rest of SA)

What to Expect in Our Report?

(1) A complete section of the Cold Chain Packaging market report is dedicated for market dynamics, which include influence factors, market drivers, challenges, opportunities, and trends.

(2) Another broad section of the research study is reserved for regional analysis of the Cold Chain Packaging market where important regions and countries are assessed for their growth potential, consumption, market share, and other vital factors indicating their market growth.

(3) Players can use the competitive analysis provided in the report to build new strategies or fine-tune their existing ones to rise above market challenges and increase their share of the Cold Chain Packaging market.

(4) The report also discusses competitive situation and trends and sheds light on company expansions and merger and acquisition taking place in the Cold Chain Packaging market. Moreover, it brings to light the market concentration rate and market shares of top three and five players.

(5) Readers are provided with findings and conclusion of the research study provided in the Cold Chain Packaging Market report.

Our study encompasses major growth determinants and drivers, along with extensive segmentation areas. Through in-depth analysis of supply and sales channels, including upstream and downstream fundamentals, we present a complete market ecosystem.

If you require any specific information that is not covered currently within the scope of the report, we will provide the same as a part of the customization.

Acquire This Reports: -

https://introspectivemarketresearch.com/checkout/?user=1&_sid=16601

About us:

Introspective Market Research (introspectivemarketresearch.com) is a visionary research consulting firm dedicated to assisting our clients to grow and have a successful impact on the market. Our team at IMR is ready to assist our clients to flourish their business by offering strategies to gain success and monopoly in their respective fields. We are a global market research company, that specializes in using big data and advanced analytics to show the bigger picture of the market trends. We help our clients to think differently and build better tomorrow for all of us. We are a technology-driven research company, we analyze extremely large sets of data to discover deeper insights and provide conclusive consulting. We not only provide intelligence solutions, but we help our clients in how they can achieve their goals.

Introspective Market Research

3001 S King Drive,

Chicago, Illinois

60616 USA

Ph no: +1-773-382-1049

Email:[email protected]

0 notes

nmsc-market-pulse · 28 days

Text

Demystifying the Beta-lactam and Beta-lactamase Inhibitors Market: Trends and Insights

The Beta-lactam and Beta-lactamase Inhibitors Market represents a critical sector within the broader pharmaceutical industry, addressing the pressing global challenge of antimicrobial resistance (AMR).

According to the study by Next Move Strategy Consulting, the global Beta-lactam and Beta-lactamase Inhibitors Market size is predicted to reach USD 34.20 billion with a CAGR of 1.9% by 2030.

Request a FREE sample, here: https://www.nextmsc.com/beta-lactam-beta-lactamase-inhibitors-market/request-sample

Trends in the Beta-lactam and Beta-lactamase Inhibitors Market

Rising Prevalence of Antibiotic Resistance: Antibiotic resistance has emerged as a global public health crisis, with bacteria developing resistance to multiple classes of antibiotics. The overuse and misuse of antibiotics in human medicine, agriculture, and animal husbandry have accelerated the proliferation of resistant bacteria. In particular, the widespread dissemination of extended-spectrum beta-lactamases (ESBLs) and carbapenemases poses a significant threat to healthcare systems worldwide.

Technological Advancements in Drug Discovery: Advances in biotechnology, genomics, and computational biology are driving innovation in antimicrobial drug discovery. High-throughput screening techniques, structural biology, and virtual screening methods enable rapid identification and optimization of novel beta-lactamase inhibitors. Furthermore, the application of CRISPR-Cas9 technology facilitates the precise modification of bacterial genomes to study antimicrobial resistance mechanisms and develop novel therapeutic strategies.

Regulatory Initiatives and Antimicrobial Stewardship: Regulatory agencies are increasingly prioritizing antimicrobial stewardship and promoting the responsible use of antibiotics to mitigate the spread of resistant bacteria. In the United States, the Food and Drug Administration (FDA) has implemented guidelines for the development of antimicrobial drugs, emphasizing the importance of demonstrating clinical efficacy and safety in treating resistant infections. Similarly, the European Medicines Agency (EMA) has established regulatory frameworks to incentivize the development of new antibiotics through market exclusivity and streamlined approval processes.

Market Dynamics and Competitive Landscape: The Beta-lactam and Beta-lactamase Inhibitors Market is characterized by intense competition among pharmaceutical companies, biotechnology firms, and academic research institutions. Established players such as Pfizer, Merck & Co., and GlaxoSmithKline dominate the market with a diverse portfolio of beta-lactam antibiotics and inhibitors. However, emerging biotech startups and small to medium-sized enterprises (SMEs) are gaining traction by focusing on niche therapeutic areas, innovative drug delivery platforms, and strategic partnerships.

Collaborative Research and Development: Collaborative research consortia, public-private partnerships, and academic-industry collaborations are driving preclinical and clinical research in the field of antimicrobial drug discovery. Initiatives such as the Innovative Medicines Initiative (IMI) in Europe and the Combating Antibiotic-Resistant Bacteria Biopharmaceutical Accelerator (CARB-X) in the United States provide funding, expertise, and infrastructure to accelerate the development of novel antibiotics and beta-lactamase inhibitors.

Insights into Market Segmentation and Therapeutic Applications

The Beta-lactam and Beta-lactamase Inhibitors Market can be segmented based on product type, mechanism of action, route of administration, and therapeutic indication. Key product categories include beta-lactam antibiotics (e.g., penicillins, cephalosporins, carbapenems) and beta-lactamase inhibitors (e.g., clavulanic acid, sulbactam, tazobactam). Mechanistically, beta-lactamase inhibitors can be classified as competitive or suicide inhibitors, depending on their mode of enzyme inhibition. Furthermore, beta-lactam and beta-lactamase inhibitors can be administered via various routes, including oral, intravenous, and intramuscular routes, depending on the severity and site of infection.

Therapeutically, beta-lactam and beta-lactamase inhibitors are indicated for the treatment of a wide range of bacterial infections, including respiratory tract infections, urinary tract infections, skin and soft tissue infections, and intra-abdominal infections. Additionally, combination therapy with beta-lactam antibiotics and inhibitors has demonstrated efficacy against multidrug-resistant pathogens, including methicillin-resistant Staphylococcus aureus (MRSA), extended-spectrum beta-lactamase (ESBL)-producing Enterobacteriaceae, and carbapenem-resistant Enterobacteriaceae (CRE).

Future Perspectives and Challenges

Despite significant progress in antimicrobial drug discovery, the Beta-lactam and Beta-lactamase Inhibitors Market faces several challenges and uncertainties. These include:

Antibiotic Resistance: The continued evolution and dissemination of antibiotic-resistant bacteria pose a formidable challenge to the effectiveness of beta-lactam antibiotics and inhibitors. Strategies to combat resistance include the development of novel antibiotics with alternative mechanisms of action, combination therapy approaches, and the implementation of infection prevention and control measures.

Regulatory Hurdles: Regulatory agencies require robust clinical evidence to support the approval and marketing of new antibiotics and beta-lactamase inhibitors. Clinical trial design, patient recruitment, and endpoint selection present logistical and ethical challenges, particularly in the context of rare and multidrug-resistant infections.

Inquire before buying, here: https://www.nextmsc.com/beta-lactam-beta-lactamase-inhibitors-market/inquire-before-buying

Economic Considerations: The economic viability of antibiotic development remains a concern for pharmaceutical companies, given the high costs and uncertain returns associated with antibiotic R&D. Market incentives, reimbursement policies, and public-private partnerships are essential to incentivize investment in antibiotic innovation and ensure access to effective antimicrobial therapies.

Global Health Equity: Access to essential antibiotics and beta-lactamase inhibitors remains uneven across different regions and socioeconomic groups. Disparities in healthcare infrastructure, affordability, and antibiotic stewardship practices contribute to the persistence of infectious diseases and antimicrobial resistance in low- and middle-income countries. Addressing these disparities requires a comprehensive approach involving governments, healthcare providers, and international organizations.

Research and Development Incentives: Encouraging investment in research and development (R&D) for new antibiotics and beta-lactamase inhibitors is crucial to address gaps in the current antimicrobial pipeline. Governments, philanthropic organizations, and private-sector stakeholders can provide financial incentives, grants, and tax credits to stimulate innovation in antimicrobial drug discovery. Additionally, initiatives such as priority review vouchers and market exclusivity extensions can incentivize pharmaceutical companies to prioritize antibiotic R&D and bring new treatments to market.

Antibiotic Stewardship Programs: Implementing comprehensive antibiotic stewardship programs is essential to promote rational antibiotic use, reduce unnecessary prescribing, and mitigate the emergence and spread of antibiotic-resistant bacteria. Healthcare facilities, including hospitals, clinics, and long-term care facilities, can establish multidisciplinary teams to develop and implement evidence-based guidelines for antibiotic prescribing, monitoring, and surveillance. Moreover, education and training initiatives for healthcare providers, patients, and the public are essential to raise awareness about the risks of antibiotic misuse and the importance of responsible antibiotic use.

Surveillance and Monitoring: Strengthening global surveillance systems and monitoring mechanisms is critical to track the epidemiology of antibiotic-resistant infections, detect emerging resistance trends, and inform public health interventions. National and international surveillance networks, such as the Centers for Disease Control and Prevention (CDC) in the United States and the European Centre for Disease Prevention and Control (ECDC) in Europe, play a vital role in collecting, analyzing, and disseminating data on antimicrobial resistance patterns. Collaborative efforts to harmonize surveillance methodologies, share data, and facilitate information exchange across borders are essential to enhance global preparedness and response to antibiotic-resistant threats.

Public Awareness and Education: Promoting public awareness and education about antimicrobial resistance is key to fostering behavioral change, empowering individuals to make informed decisions about antibiotic use, and reducing demand for unnecessary antibiotics. Public health campaigns, educational materials, and social media initiatives can raise awareness about the risks of antibiotic resistance, the importance of completing antibiotic courses as prescribed, and the role of individuals in preventing the spread of resistant bacteria. Furthermore, incorporating antimicrobial resistance education into school curricula and healthcare provider training programs can cultivate a culture of responsible antibiotic stewardship from an early age.

Conclusion

The Beta-lactam and Beta-lactamase Inhibitors Market plays a vital role in addressing the global threat of antimicrobial resistance and ensuring effective treatment options for bacterial infections. By understanding the key trends, insights, and challenges within this dynamic market, stakeholders can navigate regulatory, scientific, and economic complexities to drive innovation and improve patient outcomes. Collaboration across sectors, disciplines, and geographic regions is essential to develop sustainable solutions that preserve the efficacy of beta-lactam antibiotics and safeguard public health for future generations.

#market research #market trends #global market #beta lactam #beta lactamase #antibiotics #healthcare industry

0 notes

educationseekers · 2 months

Text

Top 7 Job Options after B Tech Biotechnology

Biotechnology is a blend of biology and technology. It's like exploring a new frontier where science and innovation meet. This field has the power to change how we do things in medicine, farming, and taking care of our planet. It's a fascinating area that draws in curious minds, especially those who love both biology and engineering.

This interdisciplinary science intersects with biochemistry, genetics, and molecular biology, driving innovations in medicine, agriculture, and industry using advanced technology.

In simple terms, biotech is about discovering nature's secrets and using them to make the world a better place.

Biotechnology courses are in high demand globally, especially in India. The B Tech Biotechnology program is like a guiding star for future engineers. In four years, students dive deep into subjects like biochemistry, microbiology, genetics, molecular biology, bioinformatics and many more.

These are the basics needed to understand the world of biology. But it's not just about learning facts; it's about doing research to bring ideas to life. Students get their hands-on experience with experiments, practical training sessions, internships etc. It's a place where creativity thrives, where students are always pushing the limits and discovering new possibilities.

Shoolini University is the first and best biotechnology university in India.

The B Tech Biotechnology course at Shoolini is one of the most popular courses among students. B Tech Biotech graduates have numerous career opportunities. Career options range from Biochemist, Biomedical Engineer, Medical or Research Scientist, Microbiologist, Process Development Scientist, to Product Manager and Bioinformatician.

Let us deep dive to learn about top seven job options after B Tech Biotechnology degree.

Bioprocess Engineer

Imagine being the mastermind behind the manufacturing processes of life-saving biopharmaceuticals! As a bioprocess engineer, your role involves designing and optimizing these crucial processes. Your work ensures the efficient production of biopharmaceuticals, making a significant impact on healthcare.

Research Scientist

If you're passionate about delving into the depths of scientific inquiry, a career as a research scientist might be perfect for you. In this role, you'll conduct experiments, analyze data, and work towards developing innovative solutions as a biotechnology researcher. Your contributions to scientific research could lead to breakthrough discoveries and advancements in the field.

Geneticist

Dive into the fascinating world of genes and heredity as a geneticist. Your job entails studying genes, variations, and hereditary traits to understand diseases better and develop effective treatments. With your expertise, you can contribute to groundbreaking research aimed at combating various genetic disorders and improving human health.

Bioinformatics Analyst

Are you skilled in both biology and computer science? A career as a bioinformatics analyst might be the perfect blend for you. In this role, you'll utilize computational tools and algorithms to analyze biological data, deciphering complex genetic and molecular information. Your work plays a crucial role in advancing our understanding of biological systems and developing new therapies.

Biotechnology Consultant

Combine your knowledge of biotechnology with problem-solving skills to become a valuable biotechnology consultant. Businesses in the industry rely on consultants for expert advice and guidance. Your strategic insights can help companies navigate challenges and capitalize on opportunities in the competitive biotech landscape.

Regulatory Affairs Manager

Ensure that biotech products meet regulatory standards and guidelines as a regulatory affairs manager. This role involves staying updated on government regulations and overseeing compliance throughout the product development process. Your expertise in regulatory affairs is vital for securing approvals and bringing biotech innovations to market.

Pharmaceutical Project Manager

Take charge of overseeing the development, planning, and execution of projects related to drug discovery and development as a pharmaceutical project manager. Your organizational skills and knowledge of biotechnology play a crucial role in driving projects towards successful outcomes.

Choosing the right institution is crucial for a promising Biotech career. If you are an aspiring student looking for a fulfilling career in the dynamic sector of Biotechnology, Shoolini University is your destination.

Know More about Shoolini University

Shoolini University is the No.1 Private University in India as per Times Higher Education World University Rankings 2024 and QS World University Rankings 2024.

Shoolini is ranked No.1 in India and No.5 in Asia in citations per paper as per the QS World University Rankings Asia 2024.

The university is also leading in patent filings, with over 1300 patents from both faculty and students. Recently, one of its faculty members got their research paper published in the renowned journal "Nature." With all these achievements, Shoolini University stands out as the perfect place to study in himachal.

Shoolini offers a curriculum focused on research and growth, with 104+ modern laboratories and 10 centers of excellence. The world class faculty comprises experts from prestigious institutions like IITs, IIMs, NITs, IISc, multinational corporations, and pharmaceutical companies.

Many faculty members have international qualifications from leading global institutions, ensuring world-class education for students.

The School of Biotechnology and the School of Bio-Engineering and Food Technology at Shoolini offer various Biotechnology courses. These programs focus on practical learning, including hands-on training projects, internships at international universities, and practical sessions with industry professionals.

The university follows a unique approach where each student is encouraged to file at least one patent during their undergraduate studies.

Additionally, the fully residential undergrad Summit Research Program (SRP) allows students to carry out quality research, publish papers and file patents from the first year of study.

Wrapping Up

Biotechnology is transforming industries and creating new job opportunities. It presents a vast spectrum of possibilities for those aspiring a fulfilling career in biotechnology. Shoolini University, known as the premier biotechnology university in India, offers the perfect platform to build your career in this dynamic field. With comprehensive training and education, you'll be equipped to excel in the evolving landscape of biotechnology. Become a pioneer in shaping the future of biotech, driving positive change in our world with Shoolini University.

#biotechnolgy #university #biotech jobs #jobs

0 notes

gxpcellators9 · 2 months

Text

GxP Cellators Consultants: Pharmaceutical Biologics Cleanroom manufacturers

GxP Cellators Consultants is an industry leader in providing pharmaceutical biologics cleanroom manufacturing services. As a full-service cleanroom design and build firm, GxP Cellators specializes in constructing state-of-the-art aseptic processing facilities for biopharmaceutical companies developing innovative biologic drugs and therapies. Their expertise encompasses all aspects of cleanroom design, equipment specifications, materials selection, and cleanroom certification.

#Cleanroom manufactures #Pharmaceutical #Biologics Cleanroom manufacturers

0 notes

bhushans · 2 months

Text

Beyond Diagnosis: Exploring Global synthetic biology market

The global synthetic biology market was anticipated to increase at a profitable 23.8% CAGR throughout the forecast period, from US$ 3.75 billion in 2024 to US$ 31.73 billion by 2034. the market is expanding because to the growing demand to improve practical abilities, remodel naturally occurring systems, and create novel biological components, instruments, and systems. Due to the rising demand for bio-based chemicals, renewable fuels, and reasonably priced artificial biology-based drugs and vaccinations, the market for synthetic biology is expanding quickly. The demand for genetically modified crops to feed the world's burgeoning population is driving the synthetic biology market's advancements.

Get a Sample Copy of the Report: https://www.futuremarketinsights.com/reports/sample/rep-gb-1226

At the same time, utmost care needs to be taken to see that government protocols are followed for selling any of the synthetic biology products in the market.

Genetically engineered products, gene synthesis, DNA sequencing, NGS (next-generation sequencing), and bioinformatics are enhancing research in this field of medicine at the global level.

Future Market Insights has walked through these facts with future perspectives in its latest market study entitled ‘Synthetic Biology Market’. It has its line of expertise in the form of analysts and consultants to execute using a 360-degree approach in its primary, secondary, and tertiary modes of research.

“With discovery of novel therapeutic targets to treat diseases like cancer on the anvil, the global synthetic biology market is slated to grow voraciously in the upcoming period”, says an analyst from Future Market Insights.

Bioengineering is an interdisciplinary field of science that combines biology and engineering principles to design and build new biological systems or modify existing ones. It involves the application of engineering principles to biological systems, with the goal of creating new and useful functions that are not found in nature.

Key Takeaways

North America holds the largest market share with the US being home to maximum biopharmaceutical and pharmaceutical companies.

Europe holds a significant market share on the back of Germany. This is evident from the fact that Robert Koch Institute, in the year 2019, had 502,655 people based out of Germany diagnosed with cancer. This calls for high-level adoption of synthetic products amongst the Germans.

The Asia-Pacific is expected to be led by China. This could be credited to nigger strategic investment in research in synthetic biology, thereby boosting the bio-economy in the forecast period.

Competitive Biology

Novozymes, in January 2021, did launch Frontia GlutenEx with the objective of assisting wheat processors to increase recovery rate of gluten protein and also cut down on consumption of energy.

Merck, in February 2021, entered into partnership with BioNtech for supplying lipids for manufacturing Pfizer-BioNtech Covid-19 vaccine (BNT162b2).

Merck, in January 2021, completed acquisition of AmpTec to strengthen the product portfolio for manufacturing and developing mRNA to facilitate diagnostics, treatments, and vaccination.

Ribbon Biolabs, in January 2022, did raise a series A financing fund worth EUR 18 Million with the objective of enabling production facilities at the commercial scale along with DNA synthesis technology’s expansion in the US.

GenScript, in November 2021, did expand the gene synthesis production capacities in the US with 100% automated oligo synthesis along with sequencing platforms.

The PABC (Pennsylvania Biotechnology Center), in September 2022, did announce that Thermo Fisher Scientific joined hands as one of the founding sponsors of PABC campus at Doylestown; along with its novel B+Labs incubator in Philadelphia; wherein upcoming life science companies could catalyze the way to commercialization.

Medichem and Bota Bio, in August 2022, did commit to promote sustainability while improvising on industrial processes. The latter’s expertise with respect to enzyme engineering would be used for developing enzymes that could be effortlessly incorporated into former’s chemical processes.

Codexis, in July 2021, along with Kalsec, Inc., did announce expanding research collaboration for manufacturing Kalsec’s natural hop acid.

Key Market Players:

Thermo Fisher Scientific, Inc.

Merck KGaA

Novozymes

Agilent Technologies, Inc.

Codexis, Inc.

Bota Biosciences Inc.

Creative Biogene.

Creative Enzymes.

Enbiotix, Inc.

Illumina, Inc.

Other

Key Segment:

By Product:

Oligonucleotides

Enzymes

Synthetic Cells

Cloning Technologies Kits

Xeno-Nucleic Acids

Chassis Organism

By Application:

Healthcare

Non-Healthcare

By End User:

Biotechnology and Pharmaceutical companies

Academic and Government Research Institutes

Others

#synthetic biology market

0 notes

quantumpharmatech · 2 months

Text

Navigate Pharma Success: Expert Biopharmaceutical Consulting.

Quantum PharmaTech, a leading biopharmaceutical consulting firm, offers expert guidance for drug development, regulatory affairs, and commercialization. Get a free quote today!

#Biopharmaceutical Consulting #Quantum Pharmatech #consultant for pharmaceutical companies

0 notes

bhavesh2022 · 2 months

Text

North America Biopharmaceuticals Market Forecast Trends and Forecast up to 2028

We are excited to announce the release of our novel market research offering- “North America Biopharmaceuticals Market Size, Share and Trends | 2028 ”. This syndicate research offers a present market scenario and includes future projections. Details such as the latest trends, technologies, and opportunities are certainly exclusive perks of this report.

Both dominant market players as well as start-ups can purchase this market research. Business Market Insights added indispensable growth insights to help our clients in their business decisions. This market research is based on data and facts collected from authoritative sources. The report offers details such as market share, size, and CAGR estimates. Our analysts have performed scrutiny on the range of factors such as market drivers, and key challenges ahead of companies.

Key companies in this market are

AbbVie Inc

AGC Biologics AS

Amgen Inc

Boehringer Ingelheim International GmbH

Bristol-Myers Squibb Co

Eli Lilly and Co

Johnson & Johnson

Lonza Group AG

Thermo Fisher Scientific Inc

WuXi Biologics Inc

Objectives of North America Biopharmaceuticals Market Market Research Report -

Market Insights - Market Share, Size, CAGR, and Revenue

To evaluate Drivers, Challenges, and Opportunities in North America Biopharmaceuticals Market Market

To offer a competitive landscape- Strategies by key market players

To offer strategic recommendations for market investors.

To offer a brief on COVID-19 impact analysis.

How We Craft Our Market Research?

Business Market Insights uses syndicate market research methods to collect the data and variables. The factors were analyzed to assess the impact on the business. Our researchers analyzed consumer behavior, market trends, and brand positioning methods. The range of tactics used by us includes- Primary Research, Secondary Research, and Company Share Analysis (including Demographic information, Macro-financial pointers, graphical information, and Industry markers: Expenditure, framework, area development, and offices).

Our research teams rely on a data-driven approach to secure the most returns on investments. We help companies to build business knowledge through our reliable research. Using market segments, and budgets, we listed strategic recommendations.

Market Forecast

This report unfolds these details on North America Biopharmaceuticals Market market size, share, future outlook, and strategies. This section also covers drivers, challenges, trends, and opportunities in this market. Factors of influence are analyzed using various frameworks such as Porter’s Five, Value Chain Analysis, and Others.

Consumer Trends and Insights

Companies will be required to implement proper data analytics to understand their customer needs. This section will present insights on brand promotion, product marketing, and target consumers.

Covid-19 Epidemic Analysis

The pandemic of Covid-19 has transformed many industries including the North America Biopharmaceuticals Market. Despite the immediate fall downs, the pandemic has opened recovery as an opportunity for business to accelerate their profits. Post-COVID-19 Covid-19 consumers would want to be associated with companies making significant contributions to sustainability. These insights will focus on the creation of real awareness and change businesses will need in the post-pandemic business world.

Get it all Customised!

We offer customized insights on the North America Biopharmaceuticals Market market based on our client needs.

North America Biopharmaceuticals Market Research Solution is a Wonderful Place to Start as it offers-

Quick reliable information

Complete Description of Market

Historical insights, current and future market estimates

Brand Strategies and Consumer Insights

For any research and consultation queries reach out to us at [email protected]

Market Segmentation

This market research is based on key segments such as products, end-use industries and regions. We intend to keep our clients informed about the latest trends in the market, and potential revenue streams for the forecast period.

Key regions North America Biopharmaceuticals Market Market Research Report:

North America (U.S., Canada, Mexico)

Europe (U.K., France, Germany, Spain, Italy, Central & Eastern Europe, CIS)

Asia Pacific (China, Japan, South Korea, ASEAN, India, Rest of Asia Pacific)

Latin America (Brazil, Rest of Latin America)

The Middle East and Africa (Turkey, GCC, Rest of the Middle East and Africa)

Rest of the World...

Author’s Bio:

Bhavesh Shinde

Senior Market Research Expert at Business Market Insights

0 notes

sudheervanguri · 17 days

Text

Parexel Regulatory Affairs Associate Job Openings Bangalore Parexel, a leading consulting firm playing a pivotal role in assisting biopharmaceutical and medical device companies in navigating the intricate regulatory landscape. With a commitment to collaboration, innovation, and continuous learning, Parexel is dedicated to bringing products to market faster and ensuring their sustained success. Position Title: Regulatory Affairs Associate Location: Bengaluru, India Job Description About the Role As a Regulatory Affairs Associate at Parexel, you will contribute significantly to the success of biopharmaceutical and medical device companies by navigating the complex regulatory landscape. Leveraging your scientific, technical, and regulatory expertise, you will collaborate closely with clients to develop and implement regulatory strategies, facilitating the expedited market entry and longevity of their products. [caption id="attachment_23555" align="aligncenter" width="1200"] Parexel Regulatory Affairs Associate Job Openings Bangalore[/caption] Key Accountabilities: Project Execution: Works effectively within a team environment Works within broad project guidelines as directed by the Project Lead or Technical SME With the guidance of the project Technical SME, demonstrates the ability to prioritize work to achieve specified project outcomes Capitalizes on opportunities to improve one’s own performance and seeks feedback from the Project Lead and colleagues Applies information provided by the Project Lead or senior colleagues to complete assigned project activities Produces quality work that meets the expectations of project lead and the client May serve as a Project Lead for small scale projects or a Work Stream Lead on larger projects When serving as a Project Lead with clear guidance and support from Line Manager Responsible for project planning and set-up and routinely interacts with the assigned Project Specialist (PS) or Project Manager (PM) to appropriately control the project (e.g. project set-up, forecasting and financial entries, invoicing, etc.) Functions as the main client contact and ensures accurate project reporting is in place Ensures that the project team delivers to meet the client expectations for quality and timeliness Ensures that appropriate risk identification and issue-escalation procedures are in place Ensures project specific training compliance of the project team Ensures and/or manages project financials including provision of accurate revenue forecasts Ensures that the project team understand and work to the scope of the contract Identifies new opportunities through Change In Scope or add-on business from existing work Ensures timely project close-out activities are completed Consulting Activities and Relationship Management: Follows and implements the organization’s consulting models and methodologies under the guidance of the project lead and/or Technical SME Delivers a limited range of consulting services within personal area of expertise under the guidance of the Project Lead and/or Technical SME Completes assigned activities within project scope and objectives under the direction of the Project Lead and/or Technical SME Identifies project and internal issues to senior colleagues and Project Lead and/or Technical SME Interacts professionally at all working levels within a client organization and within PAREXEL Identifies project and/or client needs to the Project Lead and/or Technical SME Interactions result in clients expressing satisfaction with service provided Business Development: Begin networking within the industry (i.e. maintain contacts and relationships with clients once engagements are complete) Communicates potential new business lead to PC management and account managers PAREXEL-related Activities: Meets established metrics as specified in scorecard on an annual basis Completes basic job-related responsibilities, including

timesheets, expense reports, maintenance of CVs, training compliance, project deliverable archiving, participation in internal initiatives/projects Defines self-development activities with the support of management in order to keep current within the industry Skills: Project management knowledge Client-focused approach to work Results orientation Teamwork and collaboration skills Consulting skills Excellent interpersonal and intercultural communication skills, both written and verbal Critical thinking and problem-solving skills Proficiency in local language and extensive working knowledge of the English language Knowledge and Experience: Initial years of experience in an industry-related environment Education: Minimum of a Bachelor’s Degree in a Scientific or Technical Discipline APPLY ONLINE

0 notes

devikasmarketing · 2 months

Text

Bio Critical Services LLC delivers professional critical utility maintenance services with a specialized focus on the biopharmaceutical industry. Based on our personal experience with the equipment that will be maintained, we offer expert knowledge and precision in our services. Our service areas include MD, DC, and VA area.

#Bio Critical Services LLC #current good manufacturing practice in Frederick Maryland #good manufacturing practice services in Frederick Maryland

0 notes

market-spy · 3 months

Text

Microplate Readers: A Symphony of Science Unveiled

Welcome, curious minds, to the fascinating world of microplate readers — the unsung heroes of laboratories, diligently deciphering the intricate codes of genomics, proteomics, and drug discovery. In this blog, we’ll take a stroll through the Global Microplate Reader Market Report, published in November 2023, without the robotic jargon and decoding ceremonies. Get ready for a rollercoaster ride into the realm of scientific innovation and global market dynamics!

Market Overview:

In the grand theater of scientific exploration, the microplate reader market stole the spotlight, boasting a size of USD 578.12 million in 2021. Fast forward to 2022, and the market is gearing up for a crescendo, aiming to reach a harmonious USD 822.84 million by 2030. With a growth rate of 4.00% in the forecast period (2023–2030), it seems like the microplate readers are preparing for their magnum opus.

Product Performance:

Picture this — single-mode readers taking center stage, basking in the spotlight with over 60.0% market share in 2022. These performers are known for their cost-effectiveness and widespread usage, charming their way into diverse research and development environments. Meanwhile, the multi-mode readers are warming up backstage, ready to steal the show with their flexibility and convenience, promising a faster CAGR over the forecast period.

Application Extravaganza:

In the star-studded lineup of applications, drug discovery steals the show, claiming over 40.0% of the market share. These microplate readers play a pivotal role in the automated detection and analysis during cell-based assays, streamlining the drug development workflow. Genomics and proteomics research, however, are waiting in the wings, ready for their spotlight moment with a substantial CAGR projected from 2023 to 2030.

Global Geopolitical Drama:

Hold your breath — North America emerges as the prima donna, commanding over 40.0% of the market share in 2022. With a well-established biopharmaceutical and Contract Research Organization (CRO) industry, North America has been a hub of extensive research and development activities. Yet, the Asia Pacific region is tuning up for the fastest CAGR from 2023 to 2030, fueled by a burgeoning life sciences industry and the allure of contract service providers.

For More Information: https://www.skyquestt.com/report/microplate-reader-market

The Dynamics, Drivers, and Restraints:

As the curtain falls, let’s explore the dynamics driving the microplate reader market. The benefits associated with these devices, such as higher throughput and research-centric capabilities, are propelling their journey. However, beware of the storage sensitivity, as even a slight deviation from recommended conditions can lead to a tragic end for these delicate instruments.

Meet the Players:

In the competitive orchestra of the microplate reader market, familiar names like Danaher Corporation, Thermo Fisher Scientific, Inc., and BMG Labtech take the lead. Innovation is the key, and these players invest in research and development to set the trends in the industry.

Epilogue:

And there you have it — a backstage pass to the enthralling world of microplate readers. As these instruments continue to hit the high notes of innovation and reliability, laboratories worldwide are poised for a symphony of scientific breakthroughs. Until next time, keep decoding the mysteries of the microplate reader market without getting lost in the robotic humdrum.

Remember, science is a grand performance, and microplate readers are the virtuosos creating the melody of discovery!

About Us-

SkyQuest Technology Group is a Global Market Intelligence, Innovation Management & Commercialization organization that connects innovation to new markets, networks & collaborators for achieving Sustainable Development Goals.

SkyQuest Technology Consulting Pvt. Ltd.

1 Apache Way,

Westford,

Massachusetts 01886

USA (+1) 617–230–0741

Email- [email protected]

Website: https://www.skyquestt.com

0 notes

sqinsights · 3 months

Text

Microplate Readers: A Symphony of Science Unveiled

Market Overview:

Product Performance:

Application Extravaganza:

Global Geopolitical Drama:

For More Information: https://www.skyquestt.com/report/microplate-reader-market

The Dynamics, Drivers, and Restraints:

Meet the Players:

Epilogue:

Remember, science is a grand performance, and microplate readers are the virtuosos creating the melody of discovery!

About Us-

SkyQuest Technology Consulting Pvt. Ltd.

1 Apache Way,

Westford,

Massachusetts 01886

USA (+1) 617–230–0741

Email- [email protected]

Website: https://www.skyquestt.com

0 notes